New Survey Says The Use Of Blockchain In Life Science Has Tripled Since 2017

A new survey issued by The Pistoia Alliance which is a global nonprofit of life science firms is in the latest blockchain news – mainly because of some (shockingly) positive facts for the growth of blockchain.

The survey showed that 60% of the professionals in the pharmaceutical and life science sectors are either using or experimenting with blockchain – compared to the 22% of them who said the same thing last year.

What’s interesting is that 55% of the remaining 40% of the respondents – with no plans of implementing blockchain – said that the lack of skilled blockchain personnel is what is stopping them from adopting the technology.

In our latest survey, 55% respondents said that the biggest barrier to implementing #blockchain is a lack of skilled personnel. Want to know what else we found out? https://t.co/1lxy3Robrq

— The Pistoia Alliance (@PistoiaAlliance) September 27, 2018

The survey also showed that another 16% of the respondents saw blockchain as a too-difficult-to-understand technology which is why it served as a barrier to adoption. However, despite the perception that blockchain was a complex technology, the awareness regarding it as a form of technology was increasing.

The president of the Pistoia Alliance, Michael Arlington, commented the results by stating:

“Blockchain provides an additional layer of trust for scientists and their organizations. We hope the security benefits of the technology help to lessen reticence over sharing and transferring data or information, and will facilitate further cross-industry collaboration and knowledge sharing. We believe blockchain will open up new opportunities for the industry to begin sharing data more securely to advance drug discovery, ultimately making patients’ lives better.”

To sum it up, the survey also revealed that 30% of the respondents think that the medical supply chain is one area that can benefit the most from adopting blockchain.